Tag: regulatory standards
Batch Variability and Bioequivalence: Acceptable Limits Explained
Barbara Lalicki
June 11, 2026
Pharmacy
15 Comments
Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
read more
